Shield Therapeutics plc
Shield Therapeutics plc (SHIEF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
shief · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Shield Therapeutics plcYou SHIEF | $86M | N/A | — | — |
 BioSyent Inc. BIOYF | $114M | 16.34x | +0.1% | $0.80 |
 Green Growth Brands Inc. GGBXF | $0M | N/A | — | -$0.40 |
 Grown Rogue International Inc. GRUSF | $117M | 16.29x | -0.1% | $0.03 |
 HLS Therapeutics Inc. HLTRF | $99M | N/A | — | -$0.40 |
 Jushi Holdings Inc. JUSHF | $107M | N/A | — | -$0.35 |
 Kintor Pharmaceutical Limited KNTPF | $265M | N/A | — | -$0.43 |
Industry Average 2 peers with valid PE | — | 16.31x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Shield Therapeutics plc (SHIEF) measures how much investors pay for each dollar of the company's trailing earnings. SHIEF's current PE ratio of N/A is calculated by dividing its stock price of $0.08 by its TTM earnings per share of —.
Frequently asked questions
SHIEF pe ratio · 6 questionsSHIEF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.08 and TTM EPS of —. Data sourced from Financial Modeling Prep via SHIEF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Shield Therapeutics plc SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09